Intralymphatic administration of estramustine phosphate
Sakamoto, H.; Ohtani, K.; Kawamori, J.; Shirakawa, T.; Ohta, H.; Igarashi, N.; Tochigi, M.; Furuya, K.; Tsubata, K.; Tanaka, Y.
Nihon Sanka Fujinka Gakkai Zasshi 47(11): 1271-1272
1995
ISSN/ISBN: 0300-9165 PMID: 8543854 Document Number: 442095
Document emailed within 1 workday
Related Documents
Van Poppel, H.; Werbrouck, P.W.; Baert, L. 1990: Effect of estramustine phosphate on free androgens. a comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer Acta Urologica Belgica 58(4): 89-95Edsmyr, F.; Esposti, P.L.; Andersson, L. 1980: Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate Scandinavian Journal of Urology and Nephrology. Supplementum 55: 139-142
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Catane, R. 1978: Clinical experience with estramustine phosphate and predinimustine, two steroidal alkylating agents compounds Cancer Treatment Reports 62(8): 1264-1265
Awakura, Y.; Yamamoto, M.; Fukuzawa, S.; Itoh, N.; Nonomura, M.; Fukuyama, T. 2000: Clinical evaluation of estramustine phosphate and vinblastine in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 46(7): 449-452
Zgradić, I. 1987: The effect of estramustine phosphate on carcinoma cell proliferation depends on the estrogen receptor status in the cytosol Godisnjak Vojnomedicinske Akademije 29: 77-81
Gustafson, A.; Persson, B.; Tisell, L.E.; Wiklund, O.; Ohlson, R. 1977: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism Investigative Urology 15(3): 220-224
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Eklöv, S.; Mahdy, E.; Wester, K.; Björk, P.; Malmström, P.U.; Busch, C.; Nilsson, S. 1996: Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest Anticancer Research 16(4a): 1819-1822
Sulis, E.; Busilacchi, M.; Turno, R.; Monni, A.; Chessa, A.; Zizi, P.; Pani, P.; Manconi, P.E. 1976: Administration of antigen by intralymphatic route in the rat I. Humoral response to soluble antigens. (delta). Preliminary report Bollettino dell'Istituto Sieroterapico Milanese 55(3): 249-251
Levy, R.; le Maignan, C.; N'Daw, D.; Andrieu, J.M. 1997: An equivalent of anti-androgen withdrawal syndrome: decrease of prostate specific antigen and clinical response to estramustine phosphate withdrawal Presse Medicale 26(13): 611
Perkowska-Ptasińska, A.; Szewczyk, K.; Skuza, A.; Wasińska-Krawczyk, A.; Rydzewski, A. 2014: Phosphate nephropathy after administration of bowel purgative containing sodium phosphate - a case report Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 65(1): 60-65
Franch, F.; Verd, F.; Hernandez, P.; Xamena, M.; Díaz, A. 1995: Hypocalcemic tetany following the administration of phosphate enema Revista Espanola de Anestesiologia y Reanimacion 42(1): 35-36
Vernava, A.M.; O'Neal, L.W.; Palermo, V. 1987: Lethal hyperparathyroid crisis: hazards of phosphate administration Surgery 102(6): 941-948
Gutiérrez, E.; González, E.; Hernández, E.; Herrero, J.C.; Manzanera, M.J.; García, J.A.; Domínguez-Gil, B.; Praga, M. 2004: Acute hyperphosphatemia secondary to phosphate administration for bowel preparation Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24(3): 283-287
Albin, H.; Vinçon, G.; Bertolaso, D.; Dangoumau, J. 1981: Bioavailability of procainamide and disopyramide with and without concomitant administration of an antacid: aluminium phosphate Therapie 36(5): 541-546
Rapado, A.; Castrillo, J.M.; Esbrit, P.; Barranco, L.; de la Piedra, C.; Traba, M.L. 1984: Results of the administration of sodium phosphate cellulose as medical treatment of primary hyperparathyroidism Medicina Clinica 82(16): 702-704
Elmer, G.W.; Minor, L.; Meadows, G.G.; Spackman, D.H.; Riley, V. 1978: Increased tyrosine phenol-lyase activity in mice following pyridoxal phosphate administration Cancer Research 38(11 Part 1): 3663-3667
Gyenes, V.; Szabó, G.; Velich, N. 1998: Intra-arterial administration of Dalacin C phosphate (clindamycin) in the therapy of osteomyelitis of the jaws Fogorvosi Szemle 91(8-9): 257-260